Skip to main content


Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis

Fig. 4

Effect of nanocarrier CCG-222740 on a rabbit model of glaucoma filtration surgery. a Morphology of blebs after surgery and treatment with nanocarrier CCG-222740, empty liposomes or mitomycin-C (MMC) at day 14. Arrows indicate bleb edges. b Kaplan–Meier graph comparing the bleb survival between nanocarrier CCG-222740 [N = 6], empty liposomes [N = 6] and MMC [N = 6]

Back to article page